Medical & Financial Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 05684938

MEDICAL & FINANCIAL LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 January 2026

MEDICAL & FINANCIAL LIMITED

STATEMENT OF FINANCIAL POSITION

31 January 2026

	2026		2025
Note	£	£	£

Fixed assets

Intangible assets	5	70,054	85,621
Tangible assets	6	4,004	1,292
		---------	---------
		74,058	86,913

Current assets

Debtors	8	530,977	393,745
Cash at bank and in hand		486,792	357,343
		-------------	----------
		1,017,769	751,088

Creditors: amounts falling due within one year	9	136,924		133,984
		-------------		----------
Net current assets			880,845	617,104
			----------	----------
Total assets less current liabilities			954,903	704,017
			----------	----------
Net assets			954,903	704,017
			----------	----------

Capital and reserves

Called up share capital	1,000	1,000
Profit and loss account	953,903	703,017
	----------	----------
Shareholders funds	954,903	704,017
	----------	----------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

MEDICAL & FINANCIAL LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

31 January 2026

These financial statements were approved by the board of directors and authorised for issue on 20 April 2026 , and are signed on behalf of the board by:

S B Dickerson

Director

Company registration number: 05684938

MEDICAL & FINANCIAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 JANUARY 2026

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 16 Silver Lane, Needingworth, St Ives, Cambs, PE27 4SL.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, and are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

The turnover shown in the profit and loss account represents work done during the year.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all material timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Goodwill	-	10% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Equipment	-	20% reducing balance

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 3 (2025: 4 ).

5. Intangible assets

	Goodwill
	£
Cost
At 1 February 2025 and 31 January 2026	155,674
	----------
Amortisation
At 1 February 2025	70,053
Charge for the year	15,567
	----------
At 31 January 2026	85,620
	----------
Carrying amount
At 31 January 2026	70,054
	----------
At 31 January 2025	85,621
	----------

6. Tangible assets

	Equipment	Total
	£	£
Cost
At 1 February 2025	5,778	5,778
Additions	3,127	3,127
	-------	-------
At 31 January 2026	8,905	8,905
	-------	-------
Depreciation
At 1 February 2025	4,486	4,486
Charge for the year	415	415
	-------	-------
At 31 January 2026	4,901	4,901
	-------	-------
Carrying amount
At 31 January 2026	4,004	4,004
	-------	-------
At 31 January 2025	1,292	1,292
	-------	-------

7. Investments

	Loans to participating interests
	£
Cost
At 1 February 2025 and 31 January 2026	46,007
	---------
Impairment
At 1 February 2025 and 31 January 2026	46,007
	---------

Carrying amount
At 31 January 2026	–
	---------
At 31 January 2025	–
	---------

8. Debtors

	2026	2025
	£	£
Other debtors	530,977	393,745
	----------	----------

9. Creditors: amounts falling due within one year

	2026	2025
	£	£
Corporation tax	111,334	109,445
Other creditors	25,590	24,539
	----------	----------
	136,924	133,984
	----------	----------

10. Controlling party

The company is a subsidiary of Medical & Financial (Holdings) Limited and the ultimate controlling party is S B Dickerson .